Last updated on April 2019

A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis

Brief description of study

This trial will evaluate the safety, tolerability, pharmacokinetics, and efficacy of multiple oral doses of OPC-167832 in subjects with uncomplicated, smear-positive, drug-susceptible pulmonary tuberculosis (TB).

Clinical Study Identifier: NCT03678688

Find a site near you

Start Over

University of Cape Town (Pty) Ltd.

Cape Town, South Africa
  Connect »

TASK Clinical Research Centre

Cape Town, South Africa
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.